vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $11.9M, roughly 1.7× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -20.4%, a 11.7% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs 6.9%). ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -34.9%).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
ACNT vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $20.4M |
| Net Profit | $-1.0M | $-4.2M |
| Gross Margin | 14.6% | 87.3% |
| Operating Margin | -21.0% | -18.0% |
| Net Margin | -8.8% | -20.4% |
| Revenue YoY | 13.3% | 6.9% |
| Net Profit YoY | -1.2% | 64.9% |
| EPS (diluted) | $-0.11 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | $20.4M | ||
| Q3 25 | $19.7M | $19.9M | ||
| Q2 25 | $18.7M | $19.6M | ||
| Q1 25 | $24.7M | $17.5M | ||
| Q4 24 | $10.5M | $19.1M | ||
| Q3 24 | $20.9M | $20.2M | ||
| Q2 24 | $21.5M | $21.4M | ||
| Q1 24 | $28.0M | $19.3M |
| Q4 25 | $-1.0M | $-4.2M | ||
| Q3 25 | $-2.1M | $-8.2M | ||
| Q2 25 | $6.3M | $-11.9M | ||
| Q1 25 | $-2.3M | $-14.2M | ||
| Q4 24 | $-1.0M | $-11.8M | ||
| Q3 24 | $-6.2M | $-11.1M | ||
| Q2 24 | $-926.0K | $-12.3M | ||
| Q1 24 | $-5.5M | $-16.3M |
| Q4 25 | 14.6% | 87.3% | ||
| Q3 25 | 29.7% | 86.4% | ||
| Q2 25 | 26.1% | 84.8% | ||
| Q1 25 | 19.3% | 86.2% | ||
| Q4 24 | 24.3% | 86.8% | ||
| Q3 24 | 14.4% | 83.9% | ||
| Q2 24 | 13.1% | 85.8% | ||
| Q1 24 | 8.3% | 85.5% |
| Q4 25 | -21.0% | -18.0% | ||
| Q3 25 | -4.1% | -39.7% | ||
| Q2 25 | -14.4% | -59.6% | ||
| Q1 25 | -4.2% | -79.2% | ||
| Q4 24 | -25.4% | -62.5% | ||
| Q3 24 | -9.4% | -55.7% | ||
| Q2 24 | -8.6% | -59.2% | ||
| Q1 24 | -15.5% | -76.4% |
| Q4 25 | -8.8% | -20.4% | ||
| Q3 25 | -10.6% | -41.0% | ||
| Q2 25 | 33.7% | -61.0% | ||
| Q1 25 | -9.3% | -80.8% | ||
| Q4 24 | -9.8% | -62.1% | ||
| Q3 24 | -29.5% | -54.9% | ||
| Q2 24 | -4.3% | -57.7% | ||
| Q1 24 | -19.7% | -84.4% |
| Q4 25 | $-0.11 | $-0.07 | ||
| Q3 25 | $-0.22 | $-0.16 | ||
| Q2 25 | $0.65 | $-0.23 | ||
| Q1 25 | $-0.23 | $-0.28 | ||
| Q4 24 | $-0.11 | $-0.23 | ||
| Q3 24 | $-0.61 | $-0.22 | ||
| Q2 24 | $-0.09 | $-0.25 | ||
| Q1 24 | $-0.54 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $87.0M | $63.9M |
| Total Assets | $111.9M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | $92.0M | ||
| Q3 25 | $58.0M | $92.4M | ||
| Q2 25 | $60.5M | $101.5M | ||
| Q1 25 | $14.3M | $108.8M | ||
| Q4 24 | $16.1M | $120.4M | ||
| Q3 24 | $8.5M | $118.6M | ||
| Q2 24 | $3.6M | $118.2M | ||
| Q1 24 | $1.3M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | $0 | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $87.0M | $63.9M | ||
| Q3 25 | $87.1M | $64.3M | ||
| Q2 25 | $89.7M | $70.0M | ||
| Q1 25 | $91.2M | $77.6M | ||
| Q4 24 | $93.5M | $87.5M | ||
| Q3 24 | $94.7M | $95.0M | ||
| Q2 24 | $101.0M | $101.6M | ||
| Q1 24 | $102.0M | $109.2M |
| Q4 25 | $111.9M | $115.3M | ||
| Q3 25 | $119.9M | $116.3M | ||
| Q2 25 | $122.6M | $122.0M | ||
| Q1 25 | $152.5M | $129.7M | ||
| Q4 24 | $147.3M | $142.8M | ||
| Q3 24 | $148.6M | $143.6M | ||
| Q2 24 | $158.2M | $149.7M | ||
| Q1 24 | $161.0M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | 0.00× | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $-1.8M |
| Free Cash FlowOCF − Capex | $-196.0K | $-2.0M |
| FCF MarginFCF / Revenue | -1.7% | -9.7% |
| Capex IntensityCapex / Revenue | 3.9% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | $-1.8M | ||
| Q3 25 | $1.3M | $-8.7M | ||
| Q2 25 | $-1.4M | $-7.5M | ||
| Q1 25 | $-700.0K | $-11.6M | ||
| Q4 24 | $8.8M | $-3.5M | ||
| Q3 24 | $3.4M | $362.0K | ||
| Q2 24 | $2.2M | $-9.5M | ||
| Q1 24 | $263.0K | $-9.8M |
| Q4 25 | $-196.0K | $-2.0M | ||
| Q3 25 | $695.0K | $-8.9M | ||
| Q2 25 | $-1.5M | $-7.8M | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | $-3.6M | ||
| Q3 24 | $3.1M | $311.0K | ||
| Q2 24 | $1.9M | $-9.5M | ||
| Q1 24 | $25.0K | $-9.9M |
| Q4 25 | -1.7% | -9.7% | ||
| Q3 25 | 3.5% | -44.7% | ||
| Q2 25 | -8.3% | -39.6% | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | -18.9% | ||
| Q3 24 | 15.1% | 1.5% | ||
| Q2 24 | 9.1% | -44.7% | ||
| Q1 24 | 0.1% | -51.4% |
| Q4 25 | 3.9% | 0.8% | ||
| Q3 25 | 3.1% | 0.9% | ||
| Q2 25 | 0.8% | 1.1% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 3.7% | 0.7% | ||
| Q3 24 | 1.3% | 0.3% | ||
| Q2 24 | 1.0% | 0.4% | ||
| Q1 24 | 0.9% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
